AA
Abhishek Aggarwal Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Explore the complete record of transactions filed by Abhishek Aggarwal, Dirigeant. Insider active across 1 companies, notably Dr. Lal Path Labs Ltd.. In total, 21 filings have been recorded. The latest transaction was filed on 24 February 2026 — Purchase. Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Declarations 21 total
€14,330 1,500 shares @ €9.5534
Equity Shares
SEBI:fbbdfb416836614c2045b4fde14279f6c6b90cf2 · 24 Feb 2026
Ideal exit: 21 Nov 2026 (T+270) €24,009 1,750 shares @ €13.7192
Equity Shares
SEBI:af7d6c0111386e0ac314f4271d2e5ad10b4c6d89 · 30 Dec 2025
€49 500 shares @ €0.0979
Equity Shares
SEBI:f098e2394b24980b42ea2ded21b8858748b54b54 · 8 Aug 2025
Ideal exit: 5 May 2026 (T+270) €38 375 shares @ €0.1008
Equity Shares
SEBI:6512eb6373129b88b25d64b6f2781c253ae94e02 · 17 Jun 2025
Ideal exit: 14 Mar 2026 (T+270) €22,744 625 shares @ €36.3902
Equity Shares
SEBI:a10c1fd816769edfa9e07eff639fa652b0b9b0af · 10 Sept 2024
€14,697 400 shares @ €36.7426
Equity Shares
SEBI:f2e045385d1eb7bd5c539ad138ff89bd551d1056 · 30 Aug 2024
€13,572 375 shares @ €36.1913
Equity Shares
SEBI:e5b9cca0a613764bb630999c5bf8242d133ce4e5 · 28 Aug 2024
€13,298 375 shares @ €35.4622
Equity Shares
SEBI:73b33f11ca7c2cd9dcdcd089aeaaa70ed864d537 · 26 Aug 2024
€8,759 625 shares @ €14.0151
Equity Shares
SEBI:13a0881579a14330ec416bf7308229f064907b86 · 23 Aug 2024
Ideal exit: 20 May 2025 (T+270) €17,103 475 shares @ €36.0073
Equity Shares
SEBI:e298bcdcc494f4abf0f18835b4dda924f3a12799 · 21 Aug 2024
€7,885 1,625 shares @ €4.8526
Equity Shares
SEBI:593689cc408fc45d3c32cdaa52a887e539daa12d · 20 Aug 2024
Ideal exit: 17 May 2025 (T+270) €13,308 375 shares @ €35.4892
Equity Shares
SEBI:559c19649a554fe0962edfb654fa2c2517d081b8 · 16 Aug 2024
€34,462 975 shares @ €35.3461
Equity Shares
SEBI:451a1e9310cb7c60016d3a1543443e632aefe090 · 12 Aug 2024
€7,840 375 shares @ €20.9063
Equity Shares
SEBI:c0bd56948f37b859348095614c9b6b2c8b9a4d6c · 13 Aug 2024
Ideal exit: 10 May 2025 (T+270) €99 900 shares @ €0.1095
Equity Shares
SEBI:a95d64f9f2ffb2f5cb976426c2de935757771e26 · 18 Mar 2024
Ideal exit: 13 Dec 2024 (T+270) €42 375 shares @ €0.1114
Equity Shares
SEBI:5e31edb324ca5e10f01935f34e235dbf4fa84271 · 12 Dec 2023
Ideal exit: 7 Sept 2024 (T+270) €27,410 900 shares @ €30.4555
Equity Shares
SEBI:73fd36acfce94088036207d009a61870db4e2a3d · 8 Nov 2023
€56 450 shares @ €0.1247
Equity Shares
SEBI:f07234d792d01dcba0d527d2f45a0fd5b23146ca · 29 Sept 2022
Ideal exit: 26 Jun 2023 (T+270) €19,400 600 shares @ €32.3342
Equity Shares
SEBI:5214efff9fb439c1d78a1a1fc27e2dacc929982a · 25 Aug 2022
€13,745 300 shares @ €45.8158 0.0000% mcap 99.4% of flow
Equity Shares
SEBI:c4e9958db1fa6edc0295d1f9e808a496ee5f3db8 · 30 Aug 2021
€77 675 shares @ €0.1144 0.0000% mcap 0.6% of flow
Equity Shares
SEBI:cb7140b4e3f9bd47301894d4589915282b3179f0 · 16 Aug 2021
Ideal exit: 13 May 2022 (T+270) About Abhishek Aggarwal Abhishek Aggarwal is an executive at Dr. Lal Path Labs Ltd., a diagnostic services company in India. He is responsible for managing the company's operations and strategy, contributing to its development and innovation. Dr. Lal Path Labs Ltd. is known for its high-quality diagnostic services and commitment to patient health.